TBIO logo

Telesis Bio (TBIO)

Profile

Full Name

Telesis Bio, Inc.

Ticker Symbol

TBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

June 18, 2021

Indexes

Not included

Website

http://telesisbio.com

Employees

39

Key Details

Price

$0.98(+28.95%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$27.51M(+0.27% YoY)

Annual EPS

-$29.52(+0.61% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.98
TBIO price is $0.98

30-Day Relative Volume

1.59
TBIO 30-day relative volume is 1.59

Price Performance

Price Most recent change

+28.95%
TBIO price was up +28.95% on Apr 16, 2025

Price YTD change

+145%
TBIO price is up +145% since January 1st

Price 1-year change

-85.67%
TBIO price is down -85.67% year-on-year

Price 3-year change

-98.81%
TBIO price is down -98.81% over the past 3 years

Price Range

Price All-time high

$462.60
TBIO price is currently -99.79% below its historical high of $462.60

Price 3-year low

$0.25
TBIO price is currently +292.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$74.07M
TBIO market capitalization is $74.07 million

Market cap 3-year change

-98.81%
TBIO market capitalization is down -98.81% over the past 3 years

Market cap All-time high

$29.84B
TBIO market capitalization is currently -99.75% below its historical high of $29.84 billion

Market cap sector rank

44%
TBIO market capitalization is higher than 44% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
TBIO {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

0%
TBIO {parameterFullLabel} has remained unchanged over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-3.90
TBIO beta is -3.90

200-day SMA

$1.69
TBIO price is currently -42.03% below its 200-day simple moving average

50-day SMA

$0.41
TBIO price is currently +141.08% above its 50-day simple moving average

RSI

66.29
TBIO 14-day relative strength index is 66.29

Volume

1.59
TBIO 30-day relative volume is 1.59

ATR

$0.18
TBIO average true range is $0.18

10-day Historical Volatility

1047.44%
TBIO 10-day historical volatility is 1047.44%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$27.51M
TBIO annual revenue is $27.51 million

Revenue Analysts estimate

$9.20M
TBIO annual revenue is currently +199.01% higher than the consensus analysts' forecast

Revenue 1-year change

+0.27%
TBIO annual revenue is up +0.27% year-on-year

Revenue Sector rank

37.74%
TBIO annual revenue is higher than 37.74% of companies in Healthcare sector

EPS

EPS

-$29.52
TBIO annual earnings per share is -$29.52

EPS Analysts estimate

-$24.95
TBIO annual earnings per share is currently +18.32% higher than the consensus analysts' forecast

EPS 1-year change

+0.61%
TBIO annual earnings per share is up +0.61% year-on-year

EPS Sector rank

5.37%
TBIO annual earnings per share is higher than 5.37% of companies in Healthcare sector

Profit

Gross profit

$16.95M
TBIO annual gross profit is $16.95 million

Gross margin

61.62%
TBIO annual gross profit margin is 61.62%

Operating profit

-$35.15M
TBIO annual operating income is -$35.15 million

Operating margin

-127.78%
TBIO annual operating profit margin is -127.78%

Net income

-$47.72M
TBIO annual net profit is -$47.72 million

Net margin

-
TBIO annual net profit margin value is unknown

Expenses

Total expenses

$62.66M
TBIO annual total expenses is $62.66 million

Operating expenses

$52.10M
TBIO annual total operating expenses is $52.10 million

Cost of goods sold

$10.56M
TBIO annual cost of goods sold is $10.56 million

Selling, general & administrative expenses

$34.60M
TBIO annual SGA is $34.60 million

Depreciation and amortization

$4.10M
TBIO annual depreciation & amortization is $4.10 million

Interest expense

$3.10M
TBIO annual interest expense is $3.10 million

Income tax

$24.00K
TBIO annual income tax is $24.00 thousand

EBIT & EBITDA

EBIT

-$44.59M
TBIO annual earnings before interest & taxes is -$44.59 million

EBITDA

-$29.43M
TBIO annual EBITDA is -$29.43 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$70.41M
TBIO annual total assets is $70.41 million

Non current assets

$40.06M
TBIO annual long term assets is $40.06 million

Current assets

$30.35M
TBIO annual total current assets is $30.35 million

Cash and cash equivalents

$1.57M
TBIO annual cash & cash equivalents is $1.57 million

Accounts receivable

$5.99M
TBIO annual accounts receivable is $5.99 million

Inventory

$4.03M
TBIO annual inventory is $4.03 million

Liabilities

Total liabilities

$40.87M
TBIO annual total liabilities is $40.87 million

Long term liabilities

$32.69M
TBIO annual total long term liabilities is $32.69 million

Current liabilities

$8.18M
TBIO annual total current liabilities is $8.18 million

Accounts payable

$3.28M
TBIO annual accounts payable is $3.28 million

Debt

Total debt

$34.38M
TBIO annual total debt is $34.38 million

Total debt 1-year change

+60.45%
TBIO annual total debt is up +60.45% year-on-year

Long term debt

$32.56M
TBIO annual long term debt is $32.56 million

Short term debt

-
TBIO annual short term debt value is unknown

Equity & Capital

Shareholders equity

$29.54M
TBIO annual stockholders equity is $29.54 million

Book value

-$4.63M
TBIO annual book value is -$4.63 million

Retained earnings

-$161.47M
TBIO annual retained earnings is -$161.47 million

Working capital

$22.17M
TBIO annual working capital is $22.17 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$34.67M
TBIO annual cash flow from operations is -$34.67 million

Cash from operations 1-year change

+10.46%
TBIO annual cash flow from operations is up +10.46% year-on-year

Cash from investing

-$5.74M
TBIO annual cash flow from investing activities is -$5.74 million

Cash from investing 1-year change

+68.1%
TBIO annual cash flow from investing activities is up +68.1% year-on-year

Cash from financing

$11.56M
TBIO annual cash flow from financing activities is $11.56 million

Cash from financing 1-year change

+156.43%
TBIO annual cash flow from financing activities is up +156.43% year-on-year

CAPEX

CAPEX

$1.98M
TBIO annual capital expenditures is $1.98 million

CAPEX 1-year change

-55.68%
TBIO annual capital expenditures is down -55.68% year-on-year

Free Cash Flow

Free cash flow

-$36.65M
TBIO annual free cash flow is -$36.65 million

Free cash flow 1-year change

+15.14%
TBIO annual free cash flow is up +15.14% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.62%
TBIO annual gross profit margin is 61.62%

Operating margin

-127.78%
TBIO annual operating profit margin is -127.78%

Net margin

-
TBIO annual net profit margin value is unknown

ROA & ROE

ROA

-67.78%
TBIO annual return on assets is -67.78%

ROE

-161.57%
TBIO annual return on equity is -161.57%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TBIO price to earnings ratio value is unknown

PE ratio Sector rank

-
TBIO price to earnings ratio is unknown

PB Ratio

PB ratio

-2.99
TBIO price to book ratio is -2.99

PB ratio Sector rank

5.52%
TBIO price to book ratio is higher than 5.52% of companies in Healthcare sector

PS Ratio

PS ratio

4.23
TBIO price to sales ratio is 4.23

PS ratio Sector rank

62.56%
TBIO price to sales ratio is higher than 62.56% of companies in Healthcare sector

Enterprise value

Enterprise value

$103.23M
TBIO enterprise value is $103.23 million

Enterprise value Sector rank

50.95%
TBIO enterprise value is higher than 50.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.59
TBIO EV/EBITDA is -3.59

EV/EBITDA Sector rank

23.04%
TBIO EV/EBITDA is higher than 23.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.71
TBIO annual current ratio is 3.71

Quick ratio

3.22
TBIO annual quick ratio is 3.22

Leverage

Debt to equity

1.16
TBIO annual debt to equity ratio is 1.16

Interest coverage ratio

-14.36
TBIO annual interest coverage ratio is -14.36

Risk & Stability

Piotroski F-Score

3
TBIO piotroski f-score is 3

Altman Z-Score

-3.44
TBIO altman z-score is -3.44

Analyst ratings

Recent major analysts updates

Aug 11, 23 Keybanc
Sector Weight
Nov 9, 22 Keybanc
Overweight
Mar 28, 22 Keybanc
Overweight
Jul 13, 21 Keybanc
Overweight
Jul 13, 21 Jefferies
Buy
Jul 13, 21 Cowen & Co.
Outperform

Institutional Ownership

Similar stocks

Telomir Pharmaceuticals (TELO)
ADAG logo
Adagene (ADAG)
MGNX logo
MacroGenics (MGNX)
TCRX logo
TScan Therapeutics (TCRX)
ACHV logo
Achieve Life Sciences (ACHV)
ASMB logo
Assembly Biosciences (ASMB)
TNYA logo
Tenaya Therapeutics (TNYA)
CARA logo
Cara Therapeutics (CARA)
XCUR logo
Exicure (XCUR)
  • What is the ticker symbol for Telesis Bio?
  • Does Telesis Bio pay dividends?
  • What sector is Telesis Bio in?
  • What industry is Telesis Bio in?
  • What country is Telesis Bio based in?
  • When did Telesis Bio go public?
  • Is Telesis Bio in the S&P 500?
  • Is Telesis Bio in the NASDAQ 100?
  • Is Telesis Bio in the Dow Jones?
  • When does Telesis Bio report earnings?
  • Should I buy Telesis Bio stock now?

What is the ticker symbol for Telesis Bio?

The ticker symbol for Telesis Bio is NASDAQ:TBIO

Does Telesis Bio pay dividends?

No, Telesis Bio does not pay dividends

What sector is Telesis Bio in?

Telesis Bio is in the Healthcare sector

What industry is Telesis Bio in?

Telesis Bio is in the Medical Devices industry

What country is Telesis Bio based in?

Telesis Bio is headquartered in United States

When did Telesis Bio go public?

Telesis Bio's initial public offering (IPO) was on June 18, 2021

Is Telesis Bio in the S&P 500?

No, Telesis Bio is not included in the S&P 500 index

Is Telesis Bio in the NASDAQ 100?

No, Telesis Bio is not included in the NASDAQ 100 index

Is Telesis Bio in the Dow Jones?

No, Telesis Bio is not included in the Dow Jones index

When does Telesis Bio report earnings?

The date for Telesis Bio's next earnings report has not been announced yet

Should I buy Telesis Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page